BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22090118)

  • 1. Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promoters.
    Xi X; Persson LM; O'Brien MW; Mohr I; Wilson AC
    J Virol; 2012 Jan; 86(2):1021-33. PubMed ID: 22090118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.
    Chen J; Ye F; Xie J; Kuhne K; Gao SJ
    Virology; 2009 Apr; 386(2):290-302. PubMed ID: 19233445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcription factor activates the K9 (vIRF) gene through two distinct cis elements by a non-DNA-binding mechanism.
    Ueda K; Ishikawa K; Nishimura K; Sakakibara S; Do E; Yamanishi K
    J Virol; 2002 Dec; 76(23):12044-54. PubMed ID: 12414946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
    Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM
    J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.
    Lee HR; Do─čanay S; Chung B; Toth Z; Brulois K; Lee S; Kanketayeva Z; Feng P; Ha T; Jung JU
    J Virol; 2014 Feb; 88(4):2183-94. PubMed ID: 24335298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a new Kaposi's sarcoma-associated herpesvirus replication and transcription activator (RTA)-responsive element involved in RTA-mediated transactivation.
    Wen HJ; Minhas V; Wood C
    J Gen Virol; 2009 Apr; 90(Pt 4):944-953. PubMed ID: 19223488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
    Yang Z; Wood C
    J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
    Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
    J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sp3 Transcription Factor Cooperates with the Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein To Synergistically Activate Specific Viral and Cellular Gene Promoters.
    Chen LY; Chen LW; Peng KT; Hung CH; Chang PJ; Wang SS
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.
    Carroll KD; Bu W; Palmeri D; Spadavecchia S; Lynch SJ; Marras SA; Tyagi S; Lukac DM
    J Virol; 2006 Oct; 80(19):9697-709. PubMed ID: 16973574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
    Verma SC; Lan K; Choudhuri T; Robertson ES
    J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.
    Palmeri D; Spadavecchia S; Carroll KD; Lukac DM
    J Virol; 2007 Dec; 81(24):13299-314. PubMed ID: 17913801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Mapping of the Binding Sites and Structural Analysis of Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 2 Reveal that It Is a DNA-Binding Transcription Factor.
    Hu H; Dong J; Liang D; Gao Z; Bai L; Sun R; Hu H; Zhang H; Dong Y; Lan K
    J Virol; 2016 Feb; 90(3):1158-68. PubMed ID: 26537687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.
    Heinzelmann K; Scholz BA; Nowak A; Fossum E; Kremmer E; Haas J; Frank R; Kempkes B
    J Virol; 2010 Dec; 84(23):12255-64. PubMed ID: 20861242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA.
    Wei X; Bai L; Dong L; Liu H; Xing P; Zhou Z; Wu S; Lan K
    PLoS Pathog; 2019 Nov; 15(11):e1008160. PubMed ID: 31751430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.